Pharsight

Drugs that contain Insulin Lispro Recombinant

1. Humalog patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US5514646 LILLY Insulin analogs modified at position 29 of the B chain
May, 2013

(11 years ago)

US5474978 LILLY Insulin analog formulations
Jun, 2014

(9 years ago)

Drug Exclusivity Drug Exclusivity Expiration
NR(NR) Oct 12, 2015

Market Authorisation Date: 15 November, 2019

Treatment: Humalog is an insulin analog that is indicated in the treatment of patients with diabetes mellitus for the control of hyperglycemia

Dosage: INJECTABLE;INJECTION

More Information on Dosage

HUMALOG family patents

Family Patents

2. Humalog Kwikpen patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US5514646 LILLY Insulin analogs modified at position 29 of the B chain
May, 2013

(11 years ago)

US5474978 LILLY Insulin analog formulations
Jun, 2014

(9 years ago)

US7291132 LILLY Medication dispensing apparatus with triple screw threads for mechanical advantage
Aug, 2024

(2 months from now)

Drug Exclusivity Drug Exclusivity Expiration
NR(NR) Oct 12, 2015

Market Authorisation Date: 15 November, 2019

Treatment: Use for the treatment of hyperglycemia; Treatment of diabetes mellitus

Dosage: INJECTABLE;INJECTION

More Information on Dosage

HUMALOG KWIKPEN family patents

Family Patents

Stay ahead of others in designing the generic launch strategy of these 5 blockbuster drugs expiring in next 5 years.

Get the exclusive patent insights now. Don't be the last to know.

3. Humalog Kwikpen patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US6551992 ELI LILLY AND CO Stable insulin formulations
Jun, 2018

(5 years ago)

US6034054 ELI LILLY AND CO Stable insulin formulations
Jun, 2018

(5 years ago)

US7291132 ELI LILLY AND CO Medication dispensing apparatus with triple screw threads for mechanical advantage
Aug, 2024

(2 months from now)

Market Authorisation Date: 26 May, 2015

Treatment: Treatment of irritable bowel syndrome with diarrhea (ibs-d) in adults and symptoms thereof.

Dosage: SOLUTION;SUBCUTANEOUS

More Information on Dosage

HUMALOG KWIKPEN family patents

Family Patents

4. Humalog Pen patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US5514646 LILLY Insulin analogs modified at position 29 of the B chain
May, 2013

(11 years ago)

US5474978 LILLY Insulin analog formulations
Jun, 2014

(9 years ago)

Drug Exclusivity Drug Exclusivity Expiration
NR(NR) Oct 12, 2015

Market Authorisation Date: 15 November, 2019

Treatment: Humalog is an insulin analog that is indicated in the treatment of patients with diabetes mellitus for the control of hyperglycemia

Dosage: INJECTABLE;INJECTION

More Information on Dosage

HUMALOG PEN family patents

Family Patents